RecruitingPhase 3NCT06841354A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Sponsor: Merck Sharp & Dohme LLCChandler, AZ · +38 more sites
RecruitingPhase 3NCT07174336A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Sponsor: Eli Lilly and CompanyChandler, AZ · Phoenix, AZ · +126 more sites
RecruitingPhase 3NCT06492616A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceSponsor: Stemline Therapeutics, Inc.Chandler, AZ · Gilbert, AZ · Phoenix, AZ · +173 more sites
RecruitingPhase not listedNCT05059444ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationSponsor: Guardant Health, Inc.Chandler, AZ · +32 more sites